Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
344 studies found for:    pulmonary arterial hypertension | Open Studies
Show Display Options
Rank Status Study
1 Recruiting REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Macitentan
2 Recruiting Right Ventricular Metabolism in Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension;   Healthy
Intervention: Drug: 11C acetate
3 Recruiting Aerobic Exercise Training in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Other: Upper extremity aerobic exercise training;   Other: Alternative upper extremity exercises
4 Recruiting Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
Conditions: Muscle Weakness;   Pulmonary Arterial Hypertension
Intervention:
5 Recruiting Cardiac Function and Exercise Capacity in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Behavioral: Rehabilitation
6 Recruiting Spironolactone for Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Spironolactone;   Drug: Placebo
7 Recruiting The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Ambrisentan plus Spironolactone;   Drug: Ambrisentan plus Placebo
8 Recruiting A Therapeutic Open Label Study of Tocilizumab in the Treatment of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Tocilizumab
9 Recruiting Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab;   Other: Placebo
10 Recruiting A Pharmacokinetics Study for Pediatric Participants With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Tadalafil- Tablet
11 Recruiting Pulmonary Artery Denervation for Treatment of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Procedure: denervation;   Procedure: sham procedure
12 Recruiting Clinical Study Evaluating the Effects of First-line Oral cOmbination theraPy of maciTentan and tadalafIl in Patients With Newly Diagnosed pulMonary Arterial Hypertension (OPTIMA)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: macitentan;   Drug: tadalafil
13 Recruiting The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Macitentan;   Drug: Tadalafil;   Drug: Selexipag
14 Recruiting National Cohort Study of Idiopathic and Heritable Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention:
15 Recruiting An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: UT-15C (treprostinil diethanolamine)
16 Not yet recruiting Estrogen Receptor Antagonist in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Fulvestrant
17 Recruiting A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ubenimex;   Other: placebo
18 Recruiting Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Condition: Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
Interventions: Drug: Placebo capsules;   Drug: Bardoxolone methyl capsules
19 Recruiting Physiopathology of Pulmonary Arterial Hypertension: Mechanistic Studies
Condition: Idiopathic Pulmonary Arterial Hypertension
Intervention:
20 Not yet recruiting Open-Label Extension Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: ubenimex

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.